The SonoSite Solution for Safer Central Venous Catheter Insertion

August 18, 2014

The SonoSite Solution provides a ready-made, but highly modifiable and scalable, clinical pathway to reduce CVC-insertion complications through the use of point-of-care ultrasound

The SonoSite Solution for Safer Central Venous Catheter Insertion includes a guidebook and resource center that provides healthcare professionals with practice guidelines, procedure protocols, key metrics for benchmark success, educational videos and more. Most importantly, a team of Solutions Advisors support the program and help clinicians and administrators at participating institutions navigate through the wealth of available information.

“Central Venous Catheter (CVC) insertion can be risky. Both mechanical complications, such as a pneumothorax, or a Central Line-Associated Blood Stream Infection (CLABSI) can occur during the procedure," said Diku Mandavia, MD, Senior Vice President and Chief Medical Officer at FUJIFILM SonoSite, Inc. “An iatrogenic pneumothorax is deemed a high cost and preventable event at many hospitals and healthcare systems and, as of October 2012, the Center for Medicare and Medicaid Services (CMS) will not compensate hospitals for additional costs incurred from this complication.”

The SonoSite Solution is designed to be a collaboration between SonoSite and the healthcare provider. The program is rooted in quality-improvement science and includes the support of Solutions Advisors who can help guide the improvement cycle. In the guidebook, and through the resource center, SonoSite provides tools and appropriate evidence in a Plan-Do-Study-Act (PDSA) cycle format. The result is a self-guided, quality-improvement project that will help healthcare facilities eliminate complications from CVC insertions throughout their practice environment.

Subscribe to our newsletter

By filling out this form you agree to receive periodic emails from Fujifilm SonoSite and its subsidiaries about product updates, events and education. You may unsubscribe from these emails at any time.